“Hu14.18 has enormous potential to help high-risk neuroblastoma patients, the majority of whom are young children,” she said. “We are now committed to developing this immunotherapy to be ...

Blocking the METTL3 protein can increase sensitivity to chemotherapy in neuroblastoma, according to new research. The study shows how specific RNA modifications affect gene expression in the early ...

Blocking the METTL3 protein can increase sensitivity to chemotherapy in neuroblastoma, according to research from the ...

Neuroblastoma is cancer that develops from ... calling for more evidence to be gathered on the drug’s value from patients who benefitted from it via the CDF. In June 2017, brentuximab vedotin ...

A local charity and community members are gearing up to host the Lights and Ladders Brigade with a mission to deliver holiday ...

Its flagship drug, Omburtamab, was designed to target central nervous system and leptomeningeal metastases in pediatric neuroblastoma patients. Y-mAbs aimed to commercialize Omburtamab, promoting it ...

Alessandro Vasciaveo, PhD, has fond memories of being introduced to computers and programming through his father’s Apple II. ...